Recently, Beijing Yuequan Bionics Technology Co., Ltd. unveiled the successful closure of its Pre-A+ round financing, amassing hundreds of millions of yuan. This funding round saw collaborative investments from prominent entities such as Changfa Fund, Huakong Fund, Huaxia Fund, Guoli Minsheng, and Xingke Venture Capital Fund, among others. Notably, existing shareholder Qihang Investment also chose to participate further in this round. The capital raised will be strategically allocated towards team expansion, advancing research and development in core product technologies, and boosting production capacity. The aim is to bolster full-stack in-house research capabilities and drive forward the development of a bionics-embedded intelligence system that seamlessly integrates the 'brain-body-environment'. Leveraging its expertise in bionics tension-compression body robot theory and technology, Yuequan Bionics has achieved comprehensive in-house research, spanning from drive technology, sensing technology, and dexterous hands to humanoid robots. Its product portfolio comprises two key lines: bionic dexterous hands and humanoid robots, which have collectively garnered orders surpassing one hundred million yuan. These products find widespread application across various sectors, including intelligent manufacturing, inspection and maintenance, warehousing and logistics, healthcare, domestic services and elderly care, as well as special operations.